Join to view full profile
2946 E Banner Gateway DrGilbert, AZ 85234
Phone+1 480-256-6444
Fax+1 480-256-3682
Dr. Sue is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2001 - 2004
University of WashingtonResidency, Internal Medicine, 1994 - 1997
University of California San Francisco School of MedicineClass of 1994
Certifications & Licensure
NE State Medical License 2018 - 2028
AZ State Medical License 2004 - 2027
CO State Medical License 2018 - 2027
GA State Medical License 2020 - 2027
NV State Medical License 2018 - 2027
TX State Medical License 2021 - 2027
WY State Medical License 2018 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Sage Intergy Meaningful Use Edition, Sage, 2012-2017
- CMS Meaningful Use Stage 2 Certification Vitera Intergy Meaningful Use Edition, Vitera Healthcare Solutions, LLC, 2012-2017
- CMS Meaningful Use Stage 2 Certification Greenway Intergy Meaningful Use Edition, Greenway Health, LLC, 2012-2017
Clinical Trials
Publications & Presentations
PubMed
- 8 citationsOptimizing clinical outcomes for bronchoscopic lung volume reduction with Zephyr® valves.T David Koster, Pallav L Shah, Arschang Valipour, Gerard J Criner, Felix J F Herth
Respiratory Medicine. 2024-06-01 - 20 citationsEffect of zephyr endobronchial valves on dyspnea, activity levels, and quality of life at one year: Results from a randomized clinical trialMark T. Dransfield, Justin L. Garner, Surya P. Bhatt, Dirk-Jan Slebos, Karin Klooster
Annals of the American Thoracic Society. 2020-03-30 - Reply to Fitzmaurice et al. : The LIBERATE Trial: Options to Reduce the Risk of Post-procedural Pneumothorax and Length of Stay.Gerard J. Criner, Richard Sue, Frank C. Sciurba, Dirk-Jan Slebos
American Journal of Respiratory and Critical Care Medicine. 2018-12-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: